Myllia Biotechnology
PrivateCompany Overview
Myllia Biotechnology is a biotechnology company that specializes in functional genomics by combining CRISPR-based perturbations with single-cell RNA sequencing to accelerate drug target discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Synthetic Data, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myllia Biotechnology Comparables
Compare Myllia Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algen Biotechnologies | 86% | |
| Scenic Biotech | 84% | |
| Engine Biosciences | 82% | |
Myllia Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 72% MoM, reaching 19.4K.
- Feb 4, 2026
Grew 19% QoQ, from 21 to 25 employees.
Myllia Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Myllia Biotechnology's valuation, stock price, and market status.